Cellectar Biosciences (CLRB) Stock: Locks Down A Whole Corner Of The Market

Cellectar Biosciences IncĀ (NASDAQ: CLRB) is likely to have an overwhelmingly strong day in the market today, and for good reason. The company announced patent news that ultimately means that it has successfully locked down an entire corner of the market. Today, we’ll talk about the news, what it means for CLRB, and what we’ll be … Read more

Cellectar Biosciences (CLRB) Stock: Gaining On Presentation Acceptance

Cellectar Biosciences IncĀ (NASDAQ: CLRB) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced that data from a key clinical study was accepted for a presentation. Of course, this is leading to excitement among investors, sending the stock screaming for the top. Today, we’ll talk about … Read more

Cellectar Biosciences (CLRB) Stock: Reports Updated Data From CLR 131 Cohort 1

Cellectar Biosciences Inc (NASDAQ: CLRB) is setting up to have a strong week in the market this week after the company reported top-line data from a key clinical trial. Of course, the data proved to be overwhelmingly positive. Here’s what we saw from the CLRB press release… CLRB Reports Updated Clinical Data As mentioned above, … Read more

Cellectar Biosciences (CLRB) Stock: Gaining Big On New Data

Cellectar Biosciences Inc (NASDAQ: CLRB) is having an incredibly strong start to the day today in the pre-market hours, and the gains are happening for good reason. The company announced new data, suggesting enhanced outcomes due to the company’s PDC platform. Of course, this led to excitement among investors who are sending the stock toward … Read more

Cellectar Biosciences (CLRB) Stock: Announces Design Of Cohort 5 In CLR 131

Cellectar Biosciences Inc (NASDAQ: CLRB) is likely to have an overwhelmingly strong day in the market today after the company announced the design of the fifth cohort of its Phase 1 trial surrounding CLR 131. Here’s what we saw from the announcement: CLRB Announces Design Of Cohort 5 As mentioned above, Cellectar Biosciences is likely … Read more

Cellectar Biosciences (CLRB) Stock: Buy Reiterated At Ladenburg Thalmann

Cellectar Biosciences Inc (NASDAQ: CLRB) was the topic of key coverage by Ladenburg Thalmann recently. The firm reiterates its buy rating with a strong price target on the stock. Here’s what the firm had to offer… Ladenburg Thalmann Reiterates Buy On CLRB As mentioned above, Cellectar Biosciences was recently the center of a research report, … Read more

Cellectar Biosciences (CLRB) Stock: Reports Positive Clinical Data

Cellectar Biosciences Inc (NASDAQ: CLRB) is having a relatively rough day in the market today. However, the declines are far from justified. In fact, the company released overwhelmingly positive clinical data this morning that just seems to have not gotten to the right eyes. Nonetheless, a big thank you goes out to our friends at … Read more

Cellectar Biosciences (CLRB) Stock: This Is One For The Books!

Cellectar Biosciences Inc (NASDAQ: CLRB) isn’t having the best of days in the market today. However, if you take a look at the way the stock flew yesterday, you wouldn’t be very concerned. That’s because the company released data with regard to the fact that it has generated numerous PDC molecules that show incredible pharmacologic … Read more